Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Emergence Agitation in FESS
NCT07392983Completed
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine and midazolam in Emergence agitation (EA) (2 arms). Primary endpoint: Effectiveness in emergence agitation at 90 minutes. Started Jul 2025; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07392983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07392983.